Advancing ALS Drug Discovery with iPSC-Derived Neurons & Glia

Time: 11:00 am
day: Conference Day One Track A

Details:

  • BrainXell provides a range of human iPSC-derived neurons and glia from healthy and disease lines for use in drug discovery applications
  • Differentiating ALS patient lines harboring mutations in disease-relevant genes (i.e. C9ORF72, SOD1, TDP-43) into various cells of the CNS and generating isogenic controls
  • Disease modeling with mono-, co-, and triculture systems to advance personalized medicine for ALS and other neurodegenerative diseases

Speakers:

Matt Mandeville